Yifan Pharmaceutical Co., Ltd
|
It is a synthetic analogue of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor Agonist1. Liraglutide is 97% homologous to natural human GLP-1 by substituting arginine for lysine at position 341. It is manufactured by connecting the C-16 fatty acid (palmitic acid) with a glutamate spacer to the C-16 fatty acid (palmitic acid) on the remaining lysine residue of the peptide preprotein 26. |
Send Inquiry
|